HeartSciences (HSCS) Common Equity (2021 - 2026)
HeartSciences (HSCS) posted quarterly Common Equity of $226060.0 for Q2 2026, up 10.18% year-on-year from $205171.0 in Q2 2025, and up 10.18% on a QoQ basis from $205171.0 in Q4 2025.
HeartSciences (HSCS) Common Equity (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Common Equity for 6 consecutive years, with $226060.0 the latest figure, recorded in Q2 2026.
- Quarterly Common Equity rose 10.18% year-over-year to $226060.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $226060.0 (up 10.18% YoY) and the FY2026 annual result came in at $226060.0, up 10.18% from the prior year.
- Common Equity climbed to $226060.0 in Q2 2026 per HSCS's latest filing, from $205171.0 in the prior quarter.
- Over the last five years, Common Equity for HSCS reached as high as $8.6 million in Q1 2024 and fell as low as -$6.1 million in Q2 2022.
- A 5-year average of $1.5 million and a median of $656616.5 in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2023 — Common Equity sank 252.37% — and 2024, when it surged 3447.59%.
- Year by year, Common Equity stood at $1.1 million in 2022, then plunged by 252.37% to -$1.6 million in 2023, then soared by 343.48% to $4.0 million in 2024, then slumped by 94.89% to $205171.0 in 2025, then increased by 10.18% to $226060.0 in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $226060.0, $205171.0, and $4.2 million for Q2 2026, Q4 2025, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | 226,060.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 226,060.00 |
| Dec 31, 2025 | 205,171.00 |
| Oct 31, 2025 | 4.18 Mn |
| Jul 31, 2025 | 3.14 Mn |
| Apr 30, 2025 | 205,171.00 |
| Jan 31, 2025 | 1.79 Mn |
| Oct 31, 2024 | 4.02 Mn |
| Jul 31, 2024 | 5.93 Mn |
| Apr 30, 2024 | 7.32 Mn |
| Jan 31, 2024 | 8.63 Mn |
| Oct 31, 2023 | -1.65 Mn |
| Jul 31, 2023 | -519,702.00 |
| Apr 30, 2023 | 230,557.00 |
| Jan 31, 2023 | -257,912.00 |
| Oct 31, 2022 | 1.08 Mn |
| Jul 31, 2022 | 2.89 Mn |
| Apr 30, 2022 | -6.06 Mn |
| Jan 31, 2022 | -4.10 Mn |
| Oct 31, 2021 | -3.44 Mn |
| Jul 31, 2021 | -2.41 Mn |